HomeCompareSYK vs TMUS

SYK vs TMUS: Dividend Comparison 2026

SYK yields 1.04% · TMUS yields 1.91%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SYK wins by $20.8K in total portfolio value· pulled ahead in Year 3
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
TMUS
TMUS
● Live price
1.91%
Share price
$213.94
Annual div
$4.08
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.5K
Annual income
$215.75
Full TMUS calculator →

Portfolio growth — SYK vs TMUS

📍 SYK pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKTMUS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + TMUS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
TMUS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
TMUS
Annual income on $10K today (after 15% tax)
$162.10/yr
After 10yr DRIP, annual income (after tax)
$183.39/yr
At 15% tax rate, SYK beats the other by $6,857.15/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + TMUS for your $10,000?

SYK: 50%TMUS: 50%
100% TMUS50/50100% SYK
Portfolio after 10yr
$32.9K
Annual income
$4,249.36/yr
Blended yield
12.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on TMUS right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
TMUS
Analyst Ratings
42
Buy
10
Hold
1
Sell
Consensus: Buy
Price Target
$257.42
+20.3% upside vs current
Range: $235.00 — $310.00
Altman Z
1.7
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
TMUS buys
0
No recent congressional trades found for SYK or TMUS in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKTMUS
Forward yield1.04%1.91%
Annual dividend / share$3.40$4.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%0%
Portfolio after 10y$43.3K$22.5K
Annual income after 10y$8,282.98$215.75
Total dividends collected$21.0K$2.0K
Payment frequencyquarterlyquarterly
SectorHealthcareTelecom
Analyst consensusBuyBuy
Analyst price target$428.67$257.42

Year-by-year: SYK vs TMUS ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrTMUS PortfolioTMUS Income/yrGap
1$10,852$152.43$10,891$190.71$39.00TMUS
2$11,838$226.03$11,847$194.11$9.00TMUS
3← crossover$13,004$336.89$12,874$197.34+$130.00SYK
4$14,420$505.63$13,975$200.41+$445.00SYK
5$16,195$766.09$15,157$203.33+$1.0KSYK
6$18,504$1,175.64$16,424$206.09+$2.1KSYK
7$21,635$1,835.40$17,782$208.71+$3.9KSYK
8$26,082$2,932.10$19,238$211.19+$6.8KSYK
9$32,737$4,829.68$20,799$213.53+$11.9KSYK
10$43,312$8,282.98$22,470$215.75+$20.8KSYK

SYK vs TMUS: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

TMUSTelecom

T-Mobile US, Inc., together with its subsidiaries, provides mobile communications services in the United States, Puerto Rico, and the United States Virgin Islands. The company offers voice, messaging, and data services to 108.7 million customers in the postpaid, prepaid, and wholesale markets. It also provides wireless devices, including smartphones, wearables, and tablets and other mobile communication devices, as well as wireless devices and accessories. In addition, the company offers services, devices, and accessories under the T-Mobile and Metro by T-Mobile brands through its owned and operated retail stores, T-Mobile app and customer care channels, and its websites. It also sells its devices to dealers and other third-party distributors for resale through independent third-party retail outlets and various third-party websites. As of December 31, 2021, it operated approximately 102,000 macro cell and 41,000 small cell/distributed antenna system sites. The company was founded in 1994 and is headquartered in Bellevue, Washington.

Full TMUS Calculator →
📬

Get this SYK vs TMUS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.